Showing results (751-760 of 775) with videos related to

Sort By:
Pageof 78
JBMR Plus|May 1, 2024
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension periodLeanne M Ward, Wolfgang Högler, Francis H Glorieux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2019
Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric populationEvelien Snauwaert, Wim Van Biesen, Ann Raes, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2023
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose LevelErik A Imel, Francis H Glorieux, Michael P Whyte, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2026
Ceftriaxone administration reduces vascular calcification associated with experimental models of chronic kidney diseaseTeresa Obrero Sojo, Ma José Jiménez Moral, Fátima Guerrero Pavón, et al.
Gut|June 3, 2025
Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome StudyManolo Laiola, Laetitia Koppe, Amine Larabi, et al.
Clinical Genetics|August 29, 2018
A multicenter study to evaluate pulmonary function in osteogenesis imperfectaAllison Tam, Shan Chen, Evan Schauer, et al.
American Journal of Medical Genetics. Part A|December 27, 2019
Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter studyKeren Machol, Trevor D Hadley, Jake Schmidt, et al.
Human Molecular Genetics|April 1, 1997
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP)P S Rowe, C L Oudet, F Francis, et al.
Calcified Tissue International|January 23, 2021
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked HypophosphatemiaRaja Padidela, Michael P Whyte, Francis H Glorieux, et al.
Kidney International Reports|November 14, 2017
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic BiomarkerClaudia Pontillo, Zhen-Yu Zhang, Joost P Schanstra, et al.
Pageof 78